eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | Classifieds | Contact | More... | Topics | Search | Login | Buy full access   

Review

How best to fix a broken hip par 0
par 1
par 2
LM March, AC Chamberlain, ID Cameron, RG Cumming, AJM Brnabic, T Finnegan, S Kurrle, JM Schwarz, SML Nade, TKF Taylor and members of the Fractured Neck of Femur Health Outcomes Project Team*
par 3

Electronically published Monday 22 March 1999.
This is the unedited version published immediately on acceptance after internet peer review. Click here for the final edited version.

Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company

Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia ".
Click here to read the reviews of this article
Click here to make a comment
Click here to read more about the eMJA Internet peer review study
This is the first revised version of this article. Text changed in the revision is coloured dark blue.
Click here to view the original submitted version.


par 4
par 5
Abstract par 6

Introduction: Each year more than 15,000 elderly men and women are admitted to Australian hospitals with hip fractures. Due to an average length-of-stay (LOS) in excess of 13 days, this imposes a significant burden on the health care system.

par 6a

Objectives: To develop evidence-based guidelines for the treatment of proximal femoral fractures and to to optimise functional outcome while minimising hospital LOS.
par 7
Data sources: systematic literature search of MEDLINE and CINHAL computer data bases, bibliographies, current contents of key journals for years 1966 to december 1995.par 7a
Study selection: English language randomised controlled trials of all aspects of acute hospital treatment of proximal femoral fracture among subjects aged 50 years and over with non-metastatic proximal femoral fractures. par 7b
Data extraction: Two independent reviewers, blinded to authors, institution and study results, assessed study quality and treatment conclusions following a standard cochrane collaboration protocol. Where necessary a third review was performed to reach a consensus.
par 8
Results: Of the 120 articles published between January 1966 and December 1995, 97 met the inclusion criteria. Fifteen clinical interventions were reviewed. Four were supported by NHMRC level I evidence (prophylactic anticoagulants, prophylactic antibiotics, regional anaesthesia and pressure relieving mattresses), two had no supporting, randomised, controlled trial evidence (delay in time to surgery, time to mobilisation after surgery) and the remainder were classified as having Level II evidence. A review of current practice identified wide variability in these interventions across five acute hospitals in the Northern Sydney Health Service Area.
par 9
Comment.1
Comment.2
Conclusions: Guidelines for the management of hip fracture should be evidence-based to optimise functional outcome while minimizing hospital length-of-stay. Randomised controlled trial evidence (NH&MRC Levels I & II) exists for many, but not all, aspects of hip fracture treatment. A wide variability was found in current practice, supporting the need for evidence-based guidelines and for changes to be made to some aspects of current practice.
par 10
Comment.1

Introduction

par 11
Each year, fractures of the proximal femur (hip fracture) affect 4% of women and 2% of men aged 85 years or more. In 1995 this led to approximately 15,000 hospital admissions across Australia. Given current age specific hip fracture rates and the expected ageing of the population (Australian Bureau of Statistics), by the year 2021 this will more than double (pers comm A/Prof. R. G. Cumming). Conservative estimates of the current costs of acute inpatient care for these patients are $7.8 million in the Northern Sydney Area Health Service and $46.3 million for NSW1. This does not include other costs such as rehabilitation, support services, residential care, family assistance and changes in quality of life. The death rate in the subsequent 12 months is approximately 25%, which is four times greater than for community-living age-matched controls 2 . Most survivors do not return to their prefracture level of independence and physical abilities 3.
par 12
Comment.1
Comment.2
The main objective of this study was to answer the questions: What is the right thing to do? Are we doing the right thing? and then to develop evidence-based clinical guidelines. A systematic approach was taken with a focus on health outcomes, whereby we aimed to make recommendations that would optimise functional outcome while minimising hospital length-of-stay.4.
par 13
Methods par 14

"What is the right thing to do?" - Literature Review.

par 15
A systematic review of all randomised, controlled trials (RCTs) and meta-analyses that included hip fracture patients older than 50 years was performed. Cochrane Collaboration guidelines for the assessment of study quality were followed5. Guidelines for ranking the level of evidence were taken from the National Health & Medical Research Council (NH&MRC) 6. Where no RCTs were identified (time delay to operation and timing of weight-bearing after surgery), a search for observational studies was undertaken.
par 16
The main source of literature was English language articles identified from MEDLINE and CINAHL 1966 to December 1995. Search words used were: "Hip fractures", "proximal femoral fractures", "fractured neck of femur", together with specific interventions and clinical indicators (see Table 1). The searches were limited to English language, RCTs, meta-analyses, age >= 50 years and non-metastatic proximal femoral fractures.
par 17
Comment.1
Comment.2
Comment.3
Comment.4
In addition, manual searches of current issues of key specialty and general journals were conducted, with examination of reviewers’ personal literature, libraries, bibliographies of the identified published articles and personal contact with those working in areas relevant to hip fracture, including the Cochrane Collaboration Musculoskeletal Injuries Group.
par 18
Articles were distributed randomly to the assessors by the use of a random numbers table. Reviewers were experienced in the critical appraisal of scientific literature and were blinded to the authors, institutions and journal in which the reviewed articles were published. Articles were read independently by two assessors. Results and study-quality data were recorded following the Cochrane Collaboration criteria. Disagreements were resolved by a third assessment and a consensus meeting.

par 19
Comment.1

"Are we doing the right thing?" - Medical Record Audit.

par 20
The study population came from the five acute Northern Sydney Area Health Service public hospitals during the 1993/94 financial year. All admissions over the 12 month period were included. Patients with multiple injuries or fractures due to metastatic cancer were excluded. Data were extracted by trained medical record reviewers. Patients were identified with ICD-9 codes 820 and 821 and by Procedural codes 79.15, 79.35, 81.51-53.
par 21
Comment.1
Comment.2
Validation was carried out using a second independent audit by experienced reviewers on a 10% (n=73) random sub-sample across all hospitals. For reporting purposes, patients, surgeons and hospitals were identified by code number only.

par 22
Comment.1
Comment.2
Development of Evidence-Based Guidelines par 23
The key steps in the process of care for the acute management of hip fracture had been identified (see Table 1) and a specific clinical question asked for each, e.g. "Do low-pressure mattresses reduce the number and severity of pressure sores?" All supporting trial evidence was summarised in table format with author, year, interventions being tested, number of subjects, ranking of bias (low, moderate, high), adequate concealment of allocation to groups (yes/no), summary of results of the individual papers with odds ratios and 95% confidence limits, a calculation of the number needed to treat where possible and an assessment of Cochrane Treatment Conclusions (see legend, Table 1). Data were in a suitable format for meta-analysis to be performed for antibiotic prophylaxis and type of anaesthesia but summary statistics were not generated for the other treatment modalities. Full details of all articles and these summaries are available at www.mja.com.au/public/issues/iprs2/march/fnof.pdf [In pdf format; requires Adobe Acrobat Reader].
par 24
Comment.1
Comment.2
Comment.3
Comment.4
Comment.5
Comment.6
From these tables, a one page summary was generated for each clinical intervention, with recommendations for clinical practice and suggestions for future study. These were circulated for comment among the review team and the orthopaedic clinical groups.
par 25
Comment.1
Comment.2
The results of the medical literature review and medical record audit were presented to medical and nursing staff in each hospital in oral and written form. Local practice was compared to the other hospitals and to evidence-based best practice.
par 26
Following all these steps, a single page of draft guidelines was developed with NH&MRC levels of evidence listed for each clinical recommendation. These were circulated and presented for further discussion before being adopted. They formed the basis of an evidence-based clinical pathway which will be the subject of a separate paper.
par 27
Results par 28

"What is the right thing to do?"

par 29
Table 1 presents the results of the systematic literature review and the evidence-based clinical guidelines.

 

Table 1: Evidence Based Guidelines For Acute Management Of Proximal Femoral Fractures



Clinical interventions

Recommendations
Reference number
Australian NH&MRC level of evidence
Cochrane treatment conclusion
Time to surgery
Within 24 hours of admission
7 - 11
III - 1
2A
Preoperative traction
Not necessary - adequate analgesia should be given.
12-14
II
2B
Pressure Care mattress
To be in situ as soon as possible after admission to Emergency
15,16
II
2A
Oxygen therapy
O2 saturation monitored from time of admission
O2 administered for 48 hrs after surgery and if O2 saturation < 95%

17,18

II

2A
Prophylactic anticoagulants
To commence as soon as possible after admission to Emergency
19-38
I
1A
Pressure gradient stockings
To be applied as soon as possible after admission to Emergency
39
II
2A
Anaesthesia
Regional anaesthesia recommended for most patients
40
I
2A
Analgesia
Femoral nerve block in selected cases
41,42
II
2A
Prophylactic IV antibiotics
At induction of anaesthetic and for first 24 hours postop
43-54
I
1A
Type of surgery
Extra-capsular fractures: compression screw device;
Intra-capsular: hemi-arthroplasty
55-73
74-87
I
I-II
2A
2A
Surgical wound drains
Remove as soon as possible – consider from 24 hours
88-90
II
2B
Urinary catheterisation
Avoid indwelling catheters where possible
91
II
2B
Nutritional status
Routine assessment - provision of protein supplements as needed
92-96
II
2A
Mobilisation
Early assisted ambulation - by 48 hours after surgery
55-87,97
III
2A
Rehabilitation
Early assessment by specialist team
98-103
II
2A
Acute hospital length-of-stay
Early discharge to Nursing Home Early transfer to rehabilitaton

IV

par 30


Legend - Table 1

Level of evidence - NH&MRC (Australia)
I
Evidence obtained from a systematic review of all relevant RCTs
II
Evidence obtained from at least one properly designed RCT
III - 1
Evidence obtained from well-designed controlled trials without randomisation
III - 2
Evidence obtained from well-designed cohort or case-control analytic studies preferebly from more than one centre or research group
III - 3
Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments could also be regarded as this type of evidence
IV
Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.
Treatment conclusions – Cochrane
1A
Forms of care that improve outcome
1B
Forms of care that should be abandoned in light of the available evidence
1C
Forms of care that involve important trade-offs between known benefits and known adverse effects.
2A
Forms of care that appear promising, but require further evaluation.
2B
Forms of care that have not been shown to have the effects expected from them, but which may require further attention
2C
Forms of care with reasonable evidence that they are not effective for the purpose for which they have been used.

par 31
Our conclusions from the literature review addressed 15 issues and, on the basis of available evidence, we found:
    par 32
    Time to surgery (Level III) - No randomised, controlled trial evidence is available and observational studies give a range of conclusions. Early surgery (within 24-36 hours) is recommended for the majority of patients once medical assessment has been made and the patient’s condition stabilised appropriately. Undue delay to surgery inevitably increases length of stay and may lead to more complications, including more pressure sores, pneumonia and confusion. par 33
    Comment.1
    Comment.2
    Pre-operative traction (Level II) - Pre-operative skin and tibial pin traction should be abandoned for routine use. Pain should be adequately controlled with narcotic analgesia and/or nerve block. par 34
    Prevention of pressure sores (Level I) - Patients should be nursed on one of a range of foam-based low pressure mattresses rather than standard hospital mattresses. Very high risk patients should ideally be nursed on a large cell alternating pressure air mattress or similar pressure-decreasing bed. par 35
    Peri-operative oxygen therapy (Level II) - Some evidence supports its routine use for the first 72 hours after surgery. All patients should have oximetry assessment from time of Emergency admission to 48 hours after surgery and oxygen administered as necessary. par 36
    Anticoagulants (Level I) - Patients should receive unfractionated low dose heparin (LDH) or low-molecular weight heparin (LMWH), with a preference for the latter. This should commence as soon as possible after admission. par 37
    Pressure gradient stockings (Level II) - should be in place as soon as possible after admission. par 38
    Anaesthesia (Level I) - Regional anaesthesia (spinal or epidural) appears to be associated with reduced short-term mortality and morbidity (confusion and thromboembolism) when compared with general anaesthesia and is recommended for the majority of patients.. par 39
    Analgesia - Pain should be adequately controlled with narcotic analgesia before and immediately after surgery. Femoral nerve blocks are useful in selected cases (Level II). par 40
    Antibiotics (Level I) - Prophylactic antibiotics by vein should be given at induction of anaesthesia and continue for 24 hours. Prolonged antibiotic use is of no proven benefit for prophylaxis of wound infection. par 41
    Type of Surgery -
        par 42
        Undisplaced intra-capsular fractures (Level I) - should have internal fixation with a widely used treatment that is familiar to the surgeon (cancellous screws or compression screw and plate). par 43
        Displaced intra-capsular fractures (Level II) - there is no clearly superior surgical treatment. The options for surgical treatment of this fracture are internal fixation or arthroplasty. Internal fixation is associated with a higher risk of implant failure than hemiarthroplasty (femoral head replacement). At present the choice of treatment is best determined by patient factors (including age, presence of arthritis, availability and cost of the different types of treatment, surgeon experience and preference). par 44
        Extra-capsular (trochanteric) fractures (Level I) - Should be treated surgically. A sliding hip screw and plate has less chance of failure leading to re-operation, than a fixed device and may prove to be more cost-effective in the long term.
            par 45
            Drains (Level II) - May not be required as often as currently used and early removal is advised (around 24 hours after insertion). par 46
            Urinary catheterisation (Level II) - Avoid in-dwelling catheters where possible. Intermittent catheterisation is preferable and has been shown not to increase the incidence of urinary tract infections. par 47
            Protein supplementation (Level II) - All patients should have nutritional assessment so that protein supplementation can be given as indicated. par 48
            Weight-bearing after surgery (Level III) - no randomised, controlled trial evidence was available but a review of studies related to types of surgery 1 concluded that almost all patients should be mobilised on the first or second day, taking as much weight on the fractured leg as the patient can tolerate. par 49
            Rehabilitation (Level II) - Early assessment (within 3 days of admission) and active rehabilitation as soon as mobilising on a support frame is recommended for those who had been independent before their fracture.
              par 50
              Local consensus was that acute surgical ward nursing care was no longer required by most patients 4-5 days after surgery.

              par 51
              These recommended guidelines can be applied to most, but not all, patients who sustain a proximal femoral fracture. Individual circumstances and co-morbidities will always influence decision making. It is also recommended that these guidelines continue to be updated as new evidence becomes available.

              par 52

              "Are we doing the right thing?"

              par 53
              Comment.1
              Comment.2
              Seven hundred and twenty nine consecutive admissions were audited and will be the subject of a more detailed report evaluating the implementation of the guidelines. No significant variation was shown among the five acute care hospitals with respect to the patients’ age ( mean 82.4 years, 18% => 90 years), gender (81% female), admissions from nursing homes (28.7%) and fracture type (51% intra-capsular, 43% extra-capsular, 6% unknown). All patients had at least one co-morbidity, 71.7% had two or more and almost one third had five or more.
              par 54
              Comment.1
              Comment.2
              Comment.3
              Comment.4
              Comment.5
              Comment.6
              Comment.7
              There was some variation in patient outcomes. Mortality at 12 months was 18% 1 for non-nursing home patients(range across the five hospitals: min 12%, max 25%) and 38% for nursing home patients (min 31%, max 44%). At four month follow-up, the percentage of patients requiring a new nursing home admission was 16% (min 11%, max 23%).
              par 55
              There was considerable variation in the process of care(see table 1), particularly evident for waiting time for surgery, pre-operative traction, use of pressure gradient stockings, spinal anaesthesia and urinary catheterisation..
              par 56
              Comment.1
              [par 57 deleted]
              par 57
              [par 58 deleted]
              par 58
              Comment.1
              While prophylactic antibiotics (by vein) were used in all hospitals, most continued their use for longer than the 24 hours after surgery that the evidence and basic principles suggest is required. The prescription of additional oral antibiotics, for which there is no supporting evidence, was also common practice (min 32%, max 83%).
              par 59
              Wound drains were used almost universally, with the majority remaining beyond 24 hours.
              par 60
              [par 61 deleted]
              par 61
              Median time to ambulation after surgery was three days (min 2, max 5 days). Delay in walking after surgery was associated with an increased length of stay. The hospital with the longest delay also had the greatest acute care length of stay (median of 13 days compared to the overall median of 9 days).
              par 62
              Three quarters of those who were admitted from their own home were discharged to a rehabilitation facility. The median acute length of stay for these patients before transfer to that facility was 11 days (min 8 days, max 16 days).
              par 63
              Median length of stay for those patients returning to a Nursing Home was six days (min 5 days, max 9 days).
              par 64
              The day of the week on which a patient was admitted was also found to be associated with the acute care length of stay. This effect was shown both between and within the five hospitals. Patients admitted on a Thursday were likely to spend an extra two days in the acute care facility (median 11 days) compared with those admitted on other days (median 9 days). par 65
              Comment.1
              Comment.2
              par 66
              Comment.1
              Discussion par 67
              This study reports the completion of a project which followed a structured approach to health outcomes research as advocated by the NSW Health Department 4. Evidence- based guidelines for the treatment of proximal femoral fractures were developed. The methodology adhered closely to the process guidelines published by the NH&MRC 6. To our knowledge, this guideline development is the first to be performed within the context of clinical practice. Therefore, the recommendations for interventions that are considered to be best practice are realistic. The levels of evidence for each recommendation were made explicit with all the supporting evidence available for discussion. The clinical staff were involved throughout the entire process. Each step of the process was systematically developed and evaluated. The support for our conclusions, therefore, is robust.
              par 68
              Comment.1
              Current practice, identified by medical record audit, was compared to evidence-based best practice and areas of care requiring modification were identified. A number of steps in patient treatment were supported by high level evidence but wide variability in the routine use of these treatments was seen among the five participating hospitals in this single health service area.
              par 69
              Some common practices, including pre-operative traction and drains, had little or no supporting evidence for their continued use. Although not measured systematically the authors observed great variability in clinicians’ response to this information ranging from relief to frank disbelief; many showed considerable reluctance to drop a "time-honoured practice".
              par 70
              Comment.1
              Prevention strategies involving medical therapies such as prophylactic anticoagulants and antibiotics were in widespread use and compared favourably with other audits. However, non-pharmaceutical prevention strategies, including pressure-decreasing mattresses, oxygen saturation monitoring and nutritional supplements, were not in routine use in any hospital.
              par 71
              Despite high level evidence for the use of prophylactic anticoagulants, optimal timing of the initiation of anticoagulation remains in doubt, with surgical and anaesthetic staff expressing concern about its use in combination with regional anaesthesia where there is an extremely small, but never-the-less serious, risk of spinal haematoma. On the balance of available evidence the benefits appear to outweigh the risk of harm but it remains a controversial area suggesting further trials on types and timing of anticoagulants are required for this patient group.
              par 72
              The evidence that regional anaesthesia was associated with reduced mortality and morbidity compared with general anaesthesia also met with mixed response, anaesthetists being completely polarised in their views. The published meta-analysis40 did have flaws (duplication of patients, not all RCTs) but the review team re-assessed the original articles according to the standard Cochrane Collaboration protocol and performed a repeat analysis excluding studies which appeared to be duplicated and reached the same conclusion, albeit with a more conservative estimate of benefit (summary odds ratio = 0.68 for mortality with 95% CI 0.49,0.96).
              par 73
              Comment.1
              Comment.2
              Comment.3
              The optimum time delay from admission to surgical operation has long been a vexed question. Observational studies,7-11 with their inherent biases and conflicting results, were the only ones available on which to make recommendations. Delay to surgery is likely to increase the risk of complications and the total length of stay and no harm has been shown by early surgery on patients who are medically stable. There was considerable variability in delay to surgery in this study with up to 20% waiting longer than 72 hours. This may reflect the lack of availability of out-of-hours surgical facilities and, to a lesser extent, the achievement of medical stability, but these patients continue to be ‘poor surgical relations’ and do not receive the priority they deserve.
              par 74
              Comment.1
              Comment.2
              Earlier time to ambulation also carries resource implications and is partly dependent on the availability of physiotherapy staff but also on a patient’s general condition. While there are no randomised, controlled trials on the optimal time for mobilisation, a review of all trials of surgical treatment showed that ambulation on the first or second day after surgery had no adverse effects,55-87,97 and a cohort study has now been published with the same conclusions. 104
              par 75
              Comment.1
              Hospital administrators were not always able to accommodate the changes needed to implement the recommendations for early surgery and early mobilisation despite the approval of the medical and nursing staff. The day of admission appeared to influence both time delay to surgery and overall acute length of stay, suggesting that the practice of adding these patients to a routine list, rather than making special arrangements for them, may be a factor in prolonging length of stay.
              par 76
              Comment.1
              Patients requiring transfer to a rehabilitation facility generally stayed several days longer in the acute care ward than those discharged to Nursing Home care. Since all patients should be clinically stable, and most should have attempted to walk, before discharge, this suggests a need to address difficulties with the process of assessment for rehabilitation and/or the availability of rehabilitation beds. It is proposed that costs of the initial hospitalisation could be reduced by earlier transfer to rehabilitation from the more expensive acute care ward. Whether this translates into longer term cost savings remains to be determined.
              par 77
              This study identified considerable variation in current management of patients who have sustained hip fractures. It has some limitations being restricited to English language and only relating to evidence published up to january 1996. However, we would recommend that these guidelines should be applied to the majority of elderly patients being admitted with a hip fracture as we have shown that sufficient information now exists to challenge treatments based solely on tradition or individual perceptions. The current epidemic of proximal femoral fractures makes it essential for the best possible use to be made of scarce resources to achieve the best possible outcomes.
              par 78
              Comment.1
              References
                par 79
                1. March L, Chamberlain A, Cameron I et al. Prevention, treatment and rehabilitation of fractured neck of femur. Report from the Northern Sydney Area Health Service Fractured Neck of Femur Health Outcomes Project. 1996. ISBN 07310 9633 9 par 80
                2. Katelaris AG, Cumming RG. Health Status before and Mortality after Hip Fracture. Am J. Pub. Health 1996 ;86(4):557-560. par 81
                3. Cumming RG, Klineberg R, Katelaris A. Cohort study of risk of institutionalisation after hip fracture. Aust NZ J Pub Health, 1996 ;20(6):579-582. par 82
                4. Irwig L (1993) An Approach to Evaluating Health Outcomes. NSW Public Health Bulletin 4 (12), NSW Department of Health, Sydney. par 83
                5. The Cochrane Collaboration Handbook 1994. Section VI: Preparing and maintaining systematic reviews. Pages I-75. par 84
                6. NH&MRC Quality of Care and Health Outcomes Committee. Guidelines for the development and implementation of clinical practice guidelines. 1995. AGPS. ISBN 0644 356766 par 85
                7. Bredahl C, Nyholm B, Hindsholm KB, et al. Mortality after hip fracture: results of operation within 12 hours of admission. Injury 1992;23(2):83-86. par 86
                8. Dolk T. Operation in hip fracture patients - analysis of the time factor. Injury 1990; 21(6):369-372. par 87
                9. Hoerer D, Volpin G, Stein H. Results of early and delayed surgical fixation of hip fractures in the elderly: a comparative, retrospective study. Bull Hosp Joint Dis 1993;53(1):29-33. par 88
                10. Parker MJ, Pryor GA. The timing of surgery for proximal femoral fractures. J Bone Joint Surg Br 1992;74(2):203-205. par 89
                11. Villar RN, Allen SM, Barnes SJ. Hip fractures in healthy patients: operative delay versus prognosis. Br Med J Clin Res Ed 1986;293:1203-1204. par 90
                12. Anderson GH, Harper WM, Connolly CD, et al. Preoperative skin traction for fractures of the proximal femur: a randomised, prospective trial. J Bone Joint Surg Br 1993; 75(5):794-796. par 91
                13. Finsen V, Borset M, Buvik GE, Hauke I. Pre-operative traction in patients with hip fracture. Injury 1992;23(4):242-244. par 92
                14. Needoff M, Radford P, Langstaff R. Pre-operative traction for hip fractures in the elderly: a clinical trial. Injury 1993;24(5):317-8. par 93
                15. Hofman A, Geelkerken RH, Wille J, et al. Pressure sores and pressure-decreasing mattresses: controlled clinical trial. Lancet 1994;343(8897):568-571. par 94
                16. Nuffield Institute of Health, University of Leeds and the NHS Centre for Reviews and Dissemination. How effective are pressure-relieving interventions for the prevention and treatment of pressure sores? Effective Health Care Bulletin 1995;2(1). University of York. par 95
                17. Brown AG, Visram AR, Jones RD et al. Pre-operative and post-operative oxygen saturation in the elderly following spinal or general anaesthesia - an audit of current practice. Anaesth Intensive Care 1994;22(2):150-4. par 96
                18. Fugere F, Owen H, Ilsley A et al. Changes in oxygen saturation in the 72 hours after hip surgery: the effect of oxygen therapy. Anaesth Intensive Care 1994;22:724-728. par 97
                19. Agnelli G,Cosmi B, Di Fillipo P, et al. A randomised, double blind, placebo controlled trial of dermatan sulphate for prevention of DVT in hip fracture. Thromb Haemost 1992;67(2):203-8. par 98
                20. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994 ;308:235-296 par 99
                21. Barsotti J, Gruel Y, Rosset P, et al. Comparative, double-blind study of two dosage regimens of low-molecular-weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma 1990;4(4):371-375. par 100
                22. Bergqvist D, Efsing HO, Hallbook T, Hedlund T. Thrombo-embolism after elective and post-traumatic hip surgery: A controlled, prophylactic trial with dextran 70 and low-dose heparin. Acta Chir Scand 1979;145(4):213-218. par 101
                23. Bergqvist D. Orgaran in hip fracture surgery. Haemostasis 1992;22(2):104-108. par 102
                24. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by peri-operative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic and urologic surgery. NEJM 1988;318(19):1162-73. par 103
                25. Gerhart TN, Yett HS, Robertson LK, et al. Low-molecular weight heparinoid compared with warfarin for prophylaxis of deep vein thrombosis in patients who are operated on for fracture of the hip. J Bone Joint Surg Am 1991;73(4):494-502. par 104
                26. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thrombo-embolism following total hip replacement. JAMA 1994;271(22):1780-1785. par 105
                27. International Consensus Statement: Prevention of venous thrombo-embolism: a meta-analysis. 1995. unpublished. par 106
                28. Lahnborg G. Effect of low dose heparin and dihydroergotamine on frequency of post-operative deep vein thrombosis in patients undergoing post-traumatic hip surgery. Acta Chir Scand 1980;146(5):319-22. par 107
                29. Lassen MR, Borris LC, Christiansen HM et al. Clinical trials with low-molecular weight heparins in the prevention of post-operative thrombo-embolic complications: a meta-analysis. Semin Thromb Hemost 1991;17 (S3):284-290. par 108
                30. Morris GK, Mitchell JR. Warfarin sodium in the prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 1976;2(7991):869-872. par 109
                31. Morris GK, Mitchell JR. Preventing venous thrombo-embolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin and flurbiprofen. BMJ 1977;1(6060):535-537. par 110
                32. Nurmohamed MT, Rosendaal FR, Buller HR et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992;340(8812):152-156. par 111
                33. Oertli D, Hess P, Durig M et al. Prevention of deep vein thrombosis in patients with hip fractures: low-molecular weight heparin versus dextran. World J Surg 1992;16(5):980-984. par 112
                34. Pini M, Spadini E, Carluccio L et al. Dextran/aspirin versus heparin/ dihydro-ergotamine in preventing thrombosis after hip fractures. J Bone Joint Surg Br 1985;67(2):305-309. par 113
                35. Powers PJ, Gent M, Jay RM, et al. A randomised trial of less intense post-operative warfarin or aspirin therapy in the prevention of venous thrombo-embolism after surgery for fractured hip. Arch Intern Med 1989;149(4):771-774. par 114
                36. Rogers PH, Walsh PN, Marder VJ et al. Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thrombo-embolism after operation on the hip. J Bone Joint Surg Am 1978;60(6):758-762. par 115
                37. Stranks GJ, McKenzie NA, Grover ML et al . The A-V Impulse System reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture. J Bone Joint Surg Br 1992;74(5):775-778. par 116
                38. Williams JW, Eikman EA, Greenberg SH et al. Failure of low-dose heparin to prevent pulmonary embolism after hip surgery or above the knee amputation. Ann Surg 1978;188(4):468-474. par 117
                39. Fisher CG, Blachut PA, Salvian AJ et al. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomised study of compression alone versus no prophylaxis. J Orthop Trauma 1995;9(1):1-7. par 118
                40. Sorenson RM, Pace NL. Anesthetic techniques during surgical repair of femoral neck fractures: a meta-analysis. Anesthesiology 1992;77(6):1095-1104. par 119
                41. Coad NR. Post-operative analgesia following femoral neck surgery: a comparison between 3-in-1 femoral nerve block and lateral cutaneous nerve block . Eur J. Anaesthesiol 1991;8(4):287-290. par 120
                42. Hood G. Post-operative analgesia after triple nerve block for fractured neck of femur. Anaesthesia 1991;46(2):138-140. par 121
                43. Bodoky A, Neff U, Heberer M, Harder F. Antibiotic prophylaxis with two doses of cephalosporin in patients managed with internal fixation for a fracture of the hip. J Bone Joint Surg Am 1993;75(1):61-65. par 122
                44. Boyd RJ, Burke JF, Colton T. A double-blind, clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg Am 1973;55(6):1251-1258. par 123
                45. Buckley R, Hughes GN, Snodgrass T, Huchcroft SA. Perioperative Cefazolin prophylaxis in hip fracture surgery. Can J Surg 1990;33(2):122-127. par 124
                46. Ericson C, Lindgren L, Lindberg L. Cloxacillin in the prophylaxis of post-operative infections of the hip. J Bone Joint Surg Am 1973;55(4):808-813,843. par 125
                47. Garcia S, Lozano ML, Gatell JM, et al. Prophylaxis against infection: single dose cefonicid compared with multiple dose cefamandole. J Bone Joint Surg Am 1991;73(7):1044-1048. par 126
                48. Gatell JM, Garcia S, Lozano L et al. Perioperative cefamandole prophylaxis against infections. J Bone Joint Surg Am 1987;69(8):1189-1193. par 127
                49. Hedstrom SA, Lidgren L, Sernbo I et al. Cefuroxime prophylaxis in trochanteric hip fracture operations. Acta Orthop Scand 1987;58(4):361-364. par 128
                50. Hjortrup A, Sorensen C, Mejdahl S, et al. Antibiotic prophylaxis in surgery for hip fractures. Acta Orthop Scand 1990;61(2):152-153. par 129
                51. Karachalios T, Lyritis GP, Hatzopoulos E. Antibiotic prophylaxis in the surgical treatment of peri-trochanteric fractures: a comparative trial between two cephalosporins. Chemotherapy 1990;36(6):448-453. par 130
                52. McQueen MM, Littlejohn MA, Miles RS, Hughes SP. Antibiotic prophylaxis in proximal femoral fracture. Injury 1990;21(2):104-116. par 131
                53. Nungu KS, Larsson S, Wallinder L, Holm S. Bone and wound fluid concentrations of cephalosporins: oral cefadroxil and parenteral cefuroxime compared in 52 patients with a trochanteric fracture. Acta Orthop Scand 1995;66(2):161-165. par 132
                54. Tengve B, Kjellander J. Antibiotic prophylaxis in operations on trochanteric femoral fractures. J Bone Joint Surg Am 1978;60(1):97-99. par 133
                55. Aune AK, Ekeland A, Odegaard B et al. Gamma nail vs compression screw for trochanteric femoral fractures. Acta Orthop Scand 1994 ;65(2):127-130. par 134
                56. Bannister GC, Gibson AG, Ackroyd CE et al. The fixation and prognosis of trochanteric fractures: a randomised, controlled trial. Clin Orthop 1990;254:242-246. par 135
                57. Bridle SH. Fixation of intertrochanteric fractures of the femur: a randomised, prospective comparison of the gamma nail and the dynamic hip screw. J Bone Joint Surg Br 1991;73(2):330-334. par 136
                58. Chapman MW, Bowman WE, Csongradi JJ et al. The use of Ender’s pins in extra-capsular fractures of the hip. J Bone Joint Surg Am 1981;63(1):14-28. par 137
                59. Dalen N, Jacobsson B, Eriksson PA. A comparison of nail-plate fixation and Ender’s nailing in pertrochanteric fractures. J Trauma 1988;28(3):405-406. par 138
                60. Davis TR, Sher JL, Checketts RG, Porter BB. Inter-trochanteric fractures of the femur: a prospective study comparing the use of the Kuntscher-Y nail and a sliding hip screw. Injury 1988;19(6):421-426. par 139
                61. Desjardins AL, Roy A, Paiement G et al. Unstable inter-trochanteric fracture of the femur: a prospective, randomised study comparing anatomical reduction and medial displacement osteotomy. J Bone Joint Surg Br 1993;75(3):445-447. par 140
                62. Esser MP, Kassab JY, Jones DH. Trochanteric fractures of the femur: a randomised, prospective trial comparing the Jewett nail-plate with the dynamic hip screw. J Bone Joint Surg Br 1986;68(4):557-560. par 141
                63. Gargan MF, Gundle R, Simpson AH. How effective are osteotomies for unstable intertrochanteric fractures? J Bone Joint Surg 1994;76(5):789-792. par 142
                64. Goldhagen PR, O’Connor DR, Schwarze D, Schwartz E. A prospective, comparative study of the compression hip screw and the gamma nail. J Orthop Trauma 1994;8(5):367-372. par 143
                65. Hogh J, Lund B, Lucht U. Trochanteric and subtrochanteric fractures: the operative results in a prospective, comparative study of Ender nailing and McLaughlin osteosynthesis. Acta Orthop Scand 1981;52(6):639-643. par 144
                66. Hornby R, Evans JG, Vardon V. Operative or conservative treatment for trochanteric fractures of the femur: a randomised, epidemiological trial in elderly patients. J Bone Joint Surg Br 1989;71(4):619-623. par 145
                67. Leung KS, So WS, Shen WY, Hui PW. Gamma nails and dynamic hip screws for peri-trochanteric fractures: a randomised, prospective study in elderly patients. J Bone and Joint Surg Br 1992;74(3):345-351. par 146
                68. Lund B, Hogh J, Lucht U. Trochanteric and sub-trochanteric fractures. One year follow-up of a prospective study of Ender and McLaughlin osteosynthesis. Acta Orthop Scand 1981;52(6):645-648. par 147
                69. Nungu S, Olerud C, Rehnberg L. Treatment of intertrochanteric fractures: comparison of Ender nails and sliding screw plates. J Orthop Trauma 1991;5(4):452-457. par 148
                70. Pitsaer E, Samuel AW. Functional outcome after intertrochanteric fractures of the femur: does the implant matter? a prospective study of 100 consecutive cases. Injury 1993;24(1):35-36. par 149
                71. Sernbo I, Johnell O, Gardsell A. Locking and compression of the lag screw in trochanteric fractures is not beneficial. A prospective, randomised study of 153 cases. Acta Orthop Scand 1994;65(4):24-26. par 150
                72. Sernbo I, Johnell O, Gentz CF, Nilsson JA. Unstable inter-trochanteric fractures of the hip: treatment with Ender pins compared with a compression hip-screw. J Bone Joint Surg Am 1988;70(9):1297-1303. par 151
                73. Stark A, Brostrom LA, Barrios C et al. A prospective, randomised study of the use of sliding hip screws and Ender nails for trochanteric fractures of the femur. Int Orthop 1992;16(4):359-362. par 152
                74. Emery RJ, Broughton NS, Desai K et al. Bipolar hemiarthroplasty for sub-capital fracture of the femoral neck: a prospective, randomised trial of cemented Thompson and uncemented Moore stems. J Bone Joint Surg Br 1991;73(2):322-324. par 153
                75. Elmerson S, Andersson GB, Irstam L, Zetterberg C. Internal fixation of femoral neck fracture: no difference between the Rydell four-flanged nail and Gouffon’s pins. Acta Orthop Scand 1988;59(4):372-376. par 154
                76. Lu-Yao GL, Keller RB, Litternberg B, Wenberg JE. Outcomes after displaced fractures of the femoral neck: a meta-analysis of one hundred and six published reports. J Bone Joint Surg Am 1994;76(1)15-25. par 155
                77. Madsen F, Linde F, Andersen E et al. Fixation of displaced femoral neck fractures: A comparison between sliding screw plate and four cancellous bone screws. Acta Orthop Scand 1987;58(3):212-216. par 156
                78. Kuokkanen H, Korkala O, Antii-Poika I et al. Three cancellous bone screws versus a screw angle plate in the treatment of Garden I and II fractures of the femoral neck. Acta Orthop Belg 1991;57(1):53-57. par 157
                79. Olerud C, Rehnberg L, Hellquist E. Internal fixation of femoral neck fractures: two methods compared. J Bone Joint Surg Br 1991;73(1):16-19. par 158
                80. Radford PJ, Needoff M, Webb JK. A prospective, randomised comparison of the dynamic hip screw and the gamma locking nail. J Bone Joint Surg Br 1993;7(5):789-793. par 159
                81. Rehnberg L, Olerud C. Fixation of femoral neck fractures: comparison of the Uppsala and von Bahr screws. Acta Orthop Scand 1989;60(5):579-584. par 160
                82. Sernbo I, Johnell O, Baath L, Nilsson JA. Internal fixation of 410 cervical hip fractures: a randomised comparison of a single nail versus two hook-pins. Acta Orthop Scand 1990;61(5):411-414. par 161
                83. Sikorski JM, Barrington R. Internal fixation versus hemiarthroplasty for the displaced subcapital fracture of the femur: a prospective, randomised study. J Bone Joint Surg Br 1981;63B(3):357-361. par 162
                84. Skinner P, Riley D, Ellery J, et al. Displaced subcapital fractures of the femur: a prospective, randomized comparison of internal fixation, hemiathroplasty and total hip replacement. Injury 1989;20(5):291-293. par 163
                85. Sorensen JL, Varmarken JE, Bomler J. Internal fixation of femoral neck fractures. Dynamic Hip and Gouffon screws compared in 73 patients. Acta Orthop Scand 1992; 63(3):288-292. par 164
                86. Svenningsen S, Benum P, Nesse O, Furset OI. Internal fixation of femoral neck fractures: compression screw compared with nail plate fixation. Acta Orthop Scand 1984;55(4):423-429. par 165
                87. van Vugt AB, Oosterwijk WM, Goris RJ. Osteosynthesis versus endoprosthesis in the treatment of unstable intra-capsular hip fractures in the elderly: a randomised, clinical trial. Arch Orthop Trauma Surg 1993;113(1):39-45. par 166
                88. Cobb J P. Why use drains? J Bone Joint Surg Br 1990;72(6):993-5. par 167
                89. Varley GW, Milner SA, Turner GM et al. Ultrasound assessment of the efficacy of wound drains. J R Coll Surg Edinb 1994;39(2):97-99. par 168
                90. Varley GW, Milner SA. Wound drains in proximal femoral fracture surgery: a randomised, prospective trial of 177 patients. J R Coll Surg Edinb 1995;40(6):416-418. par 169
                91. Skelly JM, Guyatt GH, Kalbfleisch R et al. Management of urinary retention after surgical repair of hip fracture. Can Med Assoc J 1992;146(7):1185-1189. par 170
                92. Bastow MD, Rawlings J, Allison SP. Benefits of supplementary tube feeding after fractured neck of femur: a randomised, controlled trial. BMJ 1983;287:1589-1591. par 171
                93. Delmi M, Rapin CH, Bengoa JM, et al. Dietary supplementation in elderly patients with fractured neck of femur. Lancet 1990;335(8696):1013-1016. par 172
                94. Sloan JP, Wing P, Dian L, Meneilly GS. A pilot study of anabolic steroids in elderly patients with hip fractures. J Am Geriatr Soc 1992;40(11):1105-11. par 173
                95. Tkatch L, Rapin CH, Rizzoli R et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992;11(5):519-525. par 174
                96. Zauber NP, Zauber AG, Gordon FJ et al. Iron supplementation after femoral head replacement for patients with normal iron stores. JAMA 1992;267(4):525-527. par 175
                97. Brostrom LA, Barrios C, Kronberg M, et al. Clinical features and walking ability treatment of trochanteric hip fractures in the early post-operative period after hip fracture. Ann Chir et Gyn 1992;81:66-71. par 176
                98. Cameron ID, Lyle DM, Quine S. Accelerated rehabilitation after proximal femoral fracture. Disab Rehab 1993;15(1):29-34. par 177
                99. Fordham R,Thompson R, Holmes J et al. A cost-benefit study of geriatric-orthopaedic management of patients with fractured neck of femur. Centre for Health Economics, University of York. Discussion paper 1986. par 178
                100. Gilchrist WJ, Newman RJ, Hamblen DL, Williams BO. Prospective randomised study of an orthopaedic-geriatric inpatient service. BMJ 1988;297(6656):1116-1118. par 179
                101. Kennie DC, Reid J, Richardson IR et al. Effectiveness of geriatric rehabilitative care after fractures of the proximal femur in elderly women: a randomised clinical trial. BMJ 1988;297(6656):1083-1086. par 180
                102. Oyewole MF, Moloney A. A randomised, controlled trial of a high-support hospital discharge team for elderly people. Age and Ageing 1994;23:228-234. par 181
                103. Reid J, Kennie DC. Geriatric rehabilitative care after fractures of the proximal femur: one year follow-up of a randomised, clinical trial. BMJ 1989;299(6690):25-26.

                  par 182

                  Acknowledgments:

                  par 183
                  The authors acknowledge the support and assistance of the NSW Health Department’s Health Outcomes Program Grants Scheme, the Cochrane Musculoskeletal Injuries Group, the staff and administration of the five acute public hospitals, the Northern Sydney Public Health and Health Service Development Units and the Swedish Hip Fracture Group.This study would not have been possible without the help of the other members of the Project team*: Dr.Don Holt, Wayne Salvage, Peter Whitecross, Barbara Carfrae, Bronwyn Christiansen, Loray Dudley, Catherine Ferry, Jill Makaroff, Sarah Michael, Melanie Saunders, Katherine Scott, Julia Sweeney, Lorraine Heaslett, Carolyn Cole, Terry Black.

                  Positions at time of study:
                  par 184
                  Dr Lynette M March Senior Staff Specialist in Clinical Epidemiology,
                  par 185
                  NSAHS Public Health Unit.
                  par 186
                  Ms Anne C Chamberlain Project Officer, Fractured Neck of Femur
                  par 187
                  Health Outcomes Project.
                  par 188
                  Dr Ian D Cameron Director, Rehabilitation & Aged Care Services,
                  par 189
                  Hornsby Ku-ring-gai Hospital.
                  par 190
                  Dr Robert G Cumming Senior Lecturer, Department of Public Health and
                  par 191
                  Community Medicine, University of Sydney.
                  par 192
                  Mr Alan Brnabic Statistician, NSAHS Public Health Unit.
                  par 193
                  Dr Terry Finnegan Senior Staff Specialist, Department of Aged Care and Rehabilitation, The Royal North Shore Hospital.
                  par 194
                  Dr Susan Kurrle Staff Specialist, Rehabilitation & Aged Care Services,
                  par 195
                  Hornsby Ku-ring-gai Hospital.
                  par 196
                  Ms Jennifer M Schwarz Research Assistant, Fractured Neck of Femur Health Outcomes Project.
                  par 197
                  Professor Sydney ML Nade Clinical Professor, Department of Surgery, University of Sydney.
                  par 198
                  Professor Tom FK Taylor Head, University of Sydney Department of Orthopaedics & Traumatic Surgery, Royal North Shore Hospital.

                  par 199
                  Correspondence to: Assoc.Prof Lyn March,
                  par 200
                  Department of Rheumatology,
                  par 201
                  The Royal North Shore Hospital,
                  par 202
                  St. Leonards, NSW 2065
                  par 203
                  Tel: 02-9926-7351
                  par 204
                  Fax: 02-9906-1859
                  par 205



                  Click here to read the reviews of this article
                  Click here to make a comment
                  Click here to read more about the eMJA Internet peer review study
                  This is the first revised version of this article. Text changed in the revision is coloured dark blue.
                  Click here to view the original submitted version.

                  Home | Issues | eMJA shop | Terms of use | Classifieds | More... | Contact | Topics | Search

                  The Medical Journal of Australia    eMJA